8-K
filed February 9, 2023, 6:59 PM ET
ticker CALC
CIK 0001534133
leadership
confidence high
sentiment neutral
materiality 0.50
Graybug Vision appoints five new directors contingent on CalciMedica merger closing
CalciMedica, Inc.
- New directors: A. Rachel Leheny, Eric W. Roberts, Robert N. Wilson, Fred Middleton, Allan Shaw, effective at merger close.
- Resigning directors: Christy Shaffer, Christina Ackermann, Julie Eastland, Dirk Sauer, effective at merger close.
- Eric Bjerkholt resigns as Class II director, reappointed as Class I director, effective at merger close.
- Robert N. Wilson appointed Chair of the Board; committee chairs assigned to Bjerkholt (Audit), Shaw (Compensation), Wilson (Governance).
- Changes are contingent upon closing of the previously announced merger with CalciMedica, Inc.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Julie Eastland resigned as Director at CalciMedica, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
the Board received letters from Christy Shaffer, Ph.D., Christina Ackermann, Julie Eastland and Dirk Sauer, Ph.D., resigning as directors of the Company and as members of the Committees of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Allan Shaw was appointed as Director at CalciMedica, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
unanimously approved the appointment of A. Rachel Leheny, Ph.D., Eric W. Roberts, Robert N. Wilson, Fred Middleton and Allan Shaw, aged 59, 59, 82, 73 and 58, respectively, to serve as members of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
A. Rachel Leheny was appointed as Director at CalciMedica, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
unanimously approved the appointment of A. Rachel Leheny, Ph.D., Eric W. Roberts, Robert N. Wilson, Fred Middleton and Allan Shaw, aged 59, 59, 82, 73 and 58, respectively, to serve as members of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert N. Wilson was appointed as Director at CalciMedica, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
unanimously approved the appointment of A. Rachel Leheny, Ph.D., Eric W. Roberts, Robert N. Wilson, Fred Middleton and Allan Shaw, aged 59, 59, 82, 73 and 58, respectively, to serve as members of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eric W. Roberts was appointed as Director at CalciMedica, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
unanimously approved the appointment of A. Rachel Leheny, Ph.D., Eric W. Roberts, Robert N. Wilson, Fred Middleton and Allan Shaw, aged 59, 59, 82, 73 and 58, respectively, to serve as members of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Eric Bjerkholt was appointed as Class I Director at CalciMedica, Inc..
- Action
- re-appointed
- Role
- Class I Director
Exact text from the filing
Eric Bjerkholt, a current Class II member of the Board, submitted a letter to resign from the Board and was re-appointed as a Class I director, in each case, contingent upon the Closing and effective as of the Effective Time.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Robert N. Wilson was appointed as Chair of the Board at CalciMedica, Inc..
- Action
- appointed
- Role
- Chair of the Board
Exact text from the filing
Robert N. Wilson will be the Chair of the Board.
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Fred Middleton was appointed as Director at CalciMedica, Inc..
- Action
- appointed
- Role
- Director
Exact text from the filing
unanimously approved the appointment of A. Rachel Leheny, Ph.D., Eric W. Roberts, Robert N. Wilson, Fred Middleton and Allan Shaw, aged 59, 59, 82, 73 and 58, respectively, to serve as members of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christina Ackermann resigned as Director at CalciMedica, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
the Board received letters from Christy Shaffer, Ph.D., Christina Ackermann, Julie Eastland and Dirk Sauer, Ph.D., resigning as directors of the Company and as members of the Committees of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Dirk Sauer resigned as Director at CalciMedica, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
the Board received letters from Christy Shaffer, Ph.D., Christina Ackermann, Julie Eastland and Dirk Sauer, Ph.D., resigning as directors of the Company and as members of the Committees of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
Executive change
SEC 8-K Item 5.02
confidence 0.95
Christy Shaffer resigned as Director at CalciMedica, Inc..
- Action
- resigned
- Role
- Director
Exact text from the filing
the Board received letters from Christy Shaffer, Ph.D., Christina Ackermann, Julie Eastland and Dirk Sauer, Ph.D., resigning as directors of the Company and as members of the Committees of the Board, contingent upon the Closing and effective as of the Effective Time
View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.